The impact of the SARS-CoV-2 pandemic in PID patients receiving ig replacement therapy

Çekiç, ŞükrüÇiçek, FatihKılıç, Sara Şebnem2024-06-252024-06-252021-01-150271-9142https://doi.org/10.1007/s10875-020-00958-5https://link.springer.com/article/10.1007/s10875-020-00958-5https://hdl.handle.net/11452/42346eninfo:eu-repo/semantics/openAccessCovid-19Science & technologyLife sciences & biomedicineImmunologyThe impact of the SARS-CoV-2 pandemic in PID patients receiving ig replacement therapyLetter00060798970000173373741410.1007/s10875-020-00958-51573-2592